Specifically, cancer nano-vaccines co-deliver peptides and TLR9 agonists (201, 202), and gold nanoparticles the anionic TLR3 agonist poly I:C co-delivered with cationic antigen peptides (185). This evidence concerns the gene TLR9 and cancer.